New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...
The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for cognition or function in patients with early Alzheimer’s.
Biomed Industries, Inc. Presented Breakthrough Unified Theory Linking Alzheimer’s Disease, Obesity and Cardiovascular ...
Getting older is one of the biggest risks for these progressive diseases that degrade functions of the brain, the spine and the nervous system.
Hallmarks of Neurodegenerative Diseases NULISAseq Neuro 220 Panel covers the Hallmarks of Neurodegenerative diseases. New panel expands coverage for Alzheimer’s and Parkinson’s diseases including 15 ...
AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PD TM 2026. Initial data indicates significantly higher tracer ...
Add Yahoo as a preferred source to see more of our stories on Google. A computer illustration of human pegivirus, an RNA (ribonucleic acid) virus scientists believe may be linked to Parkinson's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results